Paradigm Shift in Antibiotic Resistance: Low-risk no more.
Rifaximin attaches to RNA polymerase, hindering synthesis.
Mutations in RNA alter the cell membrane, reducing access to daptomycin.
Akin to a lock (RNA) deteriorating, one key (abx) fitting can impede the effectiveness of another.
Paradigm Shift in Antibiotic Resistance: Low-risk no more.
Rifaximin attaches to RNA polymerase, hindering synthesis.
Mutations in RNA alter the cell membrane, reducing access to daptomycin.
Akin to a lock (RNA) deteriorating, one key (abx) fitting can impede the effectiveness of another.